These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 17194739

  • 1. Inhibin A is an endocrine stimulator of bone mass and strength.
    Perrien DS, Akel NS, Edwards PK, Carver AA, Bendre MS, Swain FL, Skinner RA, Hogue WR, Nicks KM, Pierson TM, Suva LJ, Gaddy D.
    Endocrinology; 2007 Apr; 148(4):1654-65. PubMed ID: 17194739
    [Abstract] [Full Text] [Related]

  • 2. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.
    Sampath TK, Simic P, Sendak R, Draca N, Bowe AE, O'Brien S, Schiavi SC, McPherson JM, Vukicevic S.
    J Bone Miner Res; 2007 Jun; 22(6):849-59. PubMed ID: 17352644
    [Abstract] [Full Text] [Related]

  • 3. Bone turnover across the menopause transition : The role of gonadal inhibins.
    Nicks KM, Fowler TW, Akel NS, Perrien DS, Suva LJ, Gaddy D.
    Ann N Y Acad Sci; 2010 Mar; 1192():153-60. PubMed ID: 20392231
    [Abstract] [Full Text] [Related]

  • 4. Inhibin and the regulation of bone mass.
    Gaddy D.
    Curr Osteoporos Rep; 2008 Jun; 6(2):51-6. PubMed ID: 18778563
    [Abstract] [Full Text] [Related]

  • 5. The skeletal effects of glucocorticoid excess override those of orchidectomy in mice.
    Weinstein RS, Jia D, Powers CC, Stewart SA, Jilka RL, Parfitt AM, Manolagas SC.
    Endocrinology; 2004 Apr; 145(4):1980-7. PubMed ID: 14715712
    [Abstract] [Full Text] [Related]

  • 6. Lasofoxifene (CP-336,156) protects against the age-related changes in bone mass, bone strength, and total serum cholesterol in intact aged male rats.
    Ke HZ, Qi H, Chidsey-Frink KL, Crawford DT, Thompson DD.
    J Bone Miner Res; 2001 Apr; 16(4):765-73. PubMed ID: 11316005
    [Abstract] [Full Text] [Related]

  • 7. DLX3 regulates bone mass by targeting genes supporting osteoblast differentiation and mineral homeostasis in vivo.
    Isaac J, Erthal J, Gordon J, Duverger O, Sun HW, Lichtler AC, Stein GS, Lian JB, Morasso MI.
    Cell Death Differ; 2014 Sep; 21(9):1365-76. PubMed ID: 24948010
    [Abstract] [Full Text] [Related]

  • 8. Inhibin-A antagonizes TGFbeta2 signaling by down-regulating cell surface expression of the TGFbeta coreceptor betaglycan.
    Looyenga BD, Wiater E, Vale W, Hammer GD.
    Mol Endocrinol; 2010 Mar; 24(3):608-20. PubMed ID: 20160125
    [Abstract] [Full Text] [Related]

  • 9. Effect of osteoblast-targeted expression of bcl-2 in bone: differential response in male and female mice.
    Pantschenko AG, Zhang W, Nahounou M, McCarthy MB, Stover ML, Lichtler AC, Clark SH, Gronowicz GA.
    J Bone Miner Res; 2005 Aug; 20(8):1414-29. PubMed ID: 16007339
    [Abstract] [Full Text] [Related]

  • 10. Reversal of bone loss in mice by nongenotropic signaling of sex steroids.
    Kousteni S, Chen JR, Bellido T, Han L, Ali AA, O'Brien CA, Plotkin L, Fu Q, Mancino AT, Wen Y, Vertino AM, Powers CC, Stewart SA, Ebert R, Parfitt AM, Weinstein RS, Jilka RL, Manolagas SC.
    Science; 2002 Oct 25; 298(5594):843-6. PubMed ID: 12399595
    [Abstract] [Full Text] [Related]

  • 11. Inhibin and p27 interact to regulate gonadal tumorigenesis.
    Cipriano SC, Chen L, Burns KH, Koff A, Matzuk MM.
    Mol Endocrinol; 2001 Jun 25; 15(6):985-96. PubMed ID: 11376116
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA-29a protects against glucocorticoid-induced bone loss and fragility in rats by orchestrating bone acquisition and resorption.
    Wang FS, Chuang PC, Lin CL, Chen MW, Ke HJ, Chang YH, Chen YS, Wu SL, Ko JY.
    Arthritis Rheum; 2013 Jun 25; 65(6):1530-40. PubMed ID: 23529662
    [Abstract] [Full Text] [Related]

  • 13. Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone.
    Lazarenko OP, Rzonca SO, Hogue WR, Swain FL, Suva LJ, Lecka-Czernik B.
    Endocrinology; 2007 Jun 25; 148(6):2669-80. PubMed ID: 17332064
    [Abstract] [Full Text] [Related]

  • 14. A novel flavonoid C-glucoside from Ulmus wallichiana preserves bone mineral density, microarchitecture and biomechanical properties in the presence of glucocorticoid by promoting osteoblast survival: a comparative study with human parathyroid hormone.
    Khan MP, Mishra JS, Sharan K, Yadav M, Singh AK, Srivastava A, Kumar S, Bhaduaria S, Maurya R, Sanyal S, Chattopadhyay N.
    Phytomedicine; 2013 Nov 15; 20(14):1256-66. PubMed ID: 23928508
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Abnormal bone architecture and biomechanical properties with near-lifetime treatment of rats with PTH.
    Sato M, Vahle J, Schmidt A, Westmore M, Smith S, Rowley E, Ma LY.
    Endocrinology; 2002 Sep 15; 143(9):3230-42. PubMed ID: 12193534
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Osteogenic activity of silymarin through enhancement of alkaline phosphatase and osteocalcin in osteoblasts and tibia-fractured mice.
    Kim JL, Park SH, Jeong D, Nam JS, Kang YH.
    Exp Biol Med (Maywood); 2012 Apr 15; 237(4):417-28. PubMed ID: 22496431
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms inducing low bone density in Duchenne muscular dystrophy in mice and humans.
    Rufo A, Del Fattore A, Capulli M, Carvello F, De Pasquale L, Ferrari S, Pierroz D, Morandi L, De Simone M, Rucci N, Bertini E, Bianchi ML, De Benedetti F, Teti A.
    J Bone Miner Res; 2011 Aug 15; 26(8):1891-903. PubMed ID: 21509823
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.